Retatrutide

‍

Format: Pen | Amount: 10mg / 15mg | Price: €159.90 / €219.90

‍

Overview

Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously, making it one of the most structurally complex metabolic compounds currently under research investigation. 

Its triple-receptor profile offers a unique model for studying how multiple metabolic pathways interact and influence systemic energy regulation at a cellular level. The glucagon receptor component adds a mechanism not present in dual-agonist compounds, and is studied for its effects on hepatic lipid-metabolism pathways in research models,distinct from GLP-1 and GIP engagement alone.

‍

Research Applications

• Studying the simultaneous activation of three distinct metabolic receptor pathways within a single compound
• Investigating how glucagon receptor activity interacts with incretin-based signalling mechanisms
• Modelling systemic energy balance and metabolic efficiency across combined receptor targets
• Comparative research into dual versus triple agonism in metabolic pathway studies

‍

Commonly Paired With

Frequently studied alongside NAD+ in protocols examining combined metabolic and cellular energy pathway research.

‍

Storage & Handling

Pre-formulated pen. Store at 2°C–8°C. Keep away from direct light and heat. Do not freeze once formulated.

‍

Regulatory Notice

For Research Use Only. Not for human or animal administration. Not a medicinal product. All handling must be performed by qualified personnel in a controlled laboratory setting.

‍